Delivery Order SPE2DP21D0002-SPE2DP24F0500
- Not listed
- This is a delivery order contract (SPE2DP16D0002|0002) awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada, for the procurement of pyridostigmine bromide, a drug used to treat nerve agent exposure. The contract has a ceiling value of $342,270.00 and a period of performance ending on December 2, 2016. It is a firm fixed-price contract with no set-aside designation. CCC serves as a prime contractor and...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada, to deliver pyridostigmine bromide with a potential value of $292,610.00. The contract is a Firm Fixed Price Delivery Order with a completion date of September 6, 2019. CCC, as the prime contractor, has previously provided a wide range of goods and services to U.S. federal agencies, including aviation and vehicle...
- The Defense Logistics Agency Medical Supply Chain division awarded a delivery order valued at $399.42K to Canadian Commercial Corporation for the procurement of Pyridostigmine Bromide, a pharmaceutical compound used in military medical applications. The contract carries a firm fixed price structure with no set-aside designation, reflecting CCC's status as a foreign government entity and Crown corporation of Canada facilitating government-to-government defense procurement relationships....
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $370,440.00 Firm Fixed Price delivery order contract to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, to provide Pyridostigmine Bromide. This contract does not have a set-aside designation. The Canadian Commercial Corporation has previously acted as a prime contractor to the Department of Defense, providing a variety of goods and services including aviation and vehicle components,...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada. The contract is for the procurement of PYRIDOSTIGMINE BROM, a pharmaceutical product, with a potential value of $337,532.10. The contract has no set-aside designation. Canadian Commercial Corporation, as the prime contractor, has provided a wide range of goods and services to U.S. federal...
- This is a $356,130.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that acts as a prime contractor to facilitate military exports and international contracting opportunities for Canadian companies. The contract is for the provision of pyridostigmine bromide, a pharmaceutical used for nerve agent antidote. The award does not have a set-aside designation....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract is for the supply of Pyridostigmine Bromide, a drug used to treat nerve agent exposure, with a potential value of $370,440.00 and a completion date of January 15, 2021. The...
- This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, for the delivery of pyridostigmine bromide with a potential value of $354,387.60. The contract is a Firm Fixed Price Delivery Order that was awarded on April 15, 2020 and has a completion date of July 14, 2020. There was no set-aside designation used for this award. Canadian Commercial Corporation has previously...
- <p>The Defense Logistics Agency Troop Support Medical (DOD-DLA) awarded a $374,220.00 firm fixed price delivery order contract to the Canadian Commercial Corporation, a company owned by the Government of Canada, to provide 8509501081 Pyridostigmine Bromide. The place of performance will be 2323 Riverside Drive in Ottawa, Ontario, Canada, with work scheduled to take place between November 1, 2022 and March 1, 2023. No subcontractors were identified.</p>
- <p>The Defense Logistics Agency Troop Support Medical (DLA) awarded a $374,220 firm fixed price delivery order contract to the Canadian Commercial Corporation, a wholly owned subsidiary of the Government of Canada, to provide 8509085571 pyridostigmine bromide. The place of performance is 2323 Riverside Drive in Ottawa, Ontario, Canada, with a period of performance from May 10, 2022 to September 12, 2022. No subcontractors were identified.</p>
- SPE2DP21D0002Indefinite Delivery Contract
- SPE2DP21D0002-SPE2DP24F0500Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract is for the procurement of pyridostigmine bromide, a pharmaceutical product, with a ceiling value of $764,820.00 and a period of performance ending on March 1, 2024. CCC frequently acts as a prime contractor to U.S. federal agencies, including the Department of Defense and its components, to facilitate the export of a wide range of goods and services from Canadian firms. This contract does not have a set-aside designation, as the contracting relationship between CCC and U.S. government agencies is international in nature. CCC manages several major indefinite delivery vehicle contracts with agencies like the DLA and Naval Sea Systems Command, enabling Canadian firms to supply products and services to U.S. federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $764.8k | 11/2/23 |